These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34820878)

  • 1. Spatial molecular profiling of a central nervous system low-grade diffusely infiltrative tumour with INI1 deficiency featuring a high-grade atypical teratoid/rhabdoid tumour component.
    Dottermusch M; Schumann Y; Kordes U; Hasselblatt M; Neumann JE
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12777. PubMed ID: 34820878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYC.
    Hasselblatt M; Thomas C; Federico A; Bens S; Hellström M; Casar-Borota O; Kordes U; Neumann JE; Dottermusch M; Rodriguez FJ; Lo AC; Cheng S; Hendson G; Hukin J; Hartmann C; Koch A; Capper D; Siebert R; Paulus W; Nemes K; Johann PD; Frühwald MC; Kool M
    Neuropathol Appl Neurobiol; 2022 Jun; 48(4):e12797. PubMed ID: 35152461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS Low-grade Diffusely Infiltrative Tumors With INI1 Deficiency, Possessing a High Propensity to Progress to Secondary INI1-deficient Rhabdoid Tumors.
    Nobusawa S; Nakata S; Nakano Y; Kawamura A; Yoshida M; Tamura A; Hasegawa D; Kosaka Y; Ito I; Watanabe R; Oishi T; Hayashi N; Ishikawa E; Sakamoto N; Okura N; Murakami C; Ichimura K; Hirato J; Yokoo H
    Am J Surg Pathol; 2020 Nov; 44(11):1459-1468. PubMed ID: 33045149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
    Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous Regression of Atypical Teratoid Rhabdoid Tumor Without Therapy in a Patient With Uncommon Regional Inactivation of SMARCB1 ( hSNF5/INI1).
    Peterson JEG; Bavle A; Mehta VP; Rauch RA; Whitehead WE; Mohila CA; Su JM; Adesina AM
    Pediatr Dev Pathol; 2019; 22(2):161-165. PubMed ID: 30470167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.
    Nobusawa S; Hirato J; Sugai T; Okura N; Yamazaki T; Yamada S; Ikota H; Nakazato Y; Yokoo H
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):167-74. PubMed ID: 26769252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
    Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
    Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).
    Bookhout C; Bouldin TW; Ellison DW
    Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
    Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M
    Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary INI1-deficient rhabdoid tumors of the central nervous system: analysis of four cases and literature review.
    Nobusawa S; Nakata S; Yoshida Y; Yamazaki T; Ueki K; Amano K; Yamamoto J; Miyahara M; Sugai T; Nakazato Y; Hirato J; Yokoo H
    Virchows Arch; 2020 May; 476(5):763-772. PubMed ID: 31707588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical teratoid/rhabdoid tumor in adults: a systematic review of the literature with meta-analysis and additional reports of 4 cases.
    Broggi G; Gianno F; Shemy DT; Massimino M; Milanaccio C; Mastronuzzi A; Rossi S; Arcella A; Giangaspero F; Antonelli M
    J Neurooncol; 2022 Mar; 157(1):1-14. PubMed ID: 35217948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical Teratoid/Rhabdoid Tumor: Revisiting Histomorphology and Immunohistochemistry With Analysis of Cyclin D1 Overexpression and
    Sali AP; Epari S; Nagaraj TS; Sahay A; Chinnaswamy G; Shetty P; Moiyadi A; Gupta T
    Int J Surg Pathol; 2021 Apr; 29(2):155-164. PubMed ID: 32703045
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
    Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
    J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 7-year-old boy presented with temporal lobe lesion.
    Zhao M; Huang T; Xiang X; Liu Y; Gu W; Liu L; Tang H; Xu J; Mao J
    Brain Pathol; 2024 May; 34(3):e13246. PubMed ID: 38355114
    [No Abstract]   [Full Text] [Related]  

  • 15. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor.
    Biegel JA; Fogelgren B; Wainwright LM; Zhou JY; Bevan H; Rorke LB
    Genes Chromosomes Cancer; 2000 May; 28(1):31-7. PubMed ID: 10738300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ewing Sarcoma and Atypical Teratoid Rhabdoid Tumor: A FISH and Immunohistochemical Comparison.
    Pacheco MC; Dolan M; Bendel A
    Pediatr Dev Pathol; 2017; 20(5):381-386. PubMed ID: 28382842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous.
    Pinto EM; Hamideh D; Bahrami A; Orr BA; Lin T; Pounds S; Zambetti GP; Pappo AS; Gajjar A; Agnihotri S; Broniscer A
    Acta Neuropathol; 2018 Aug; 136(2):315-326. PubMed ID: 29428974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SWI/SNF-deficient tumors of the central nervous system: An update.
    Hasselblatt M; Kool M; Frühwald MC
    Clin Neuropathol; 2024; 43(1):2-9. PubMed ID: 37969088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.
    Johann PD; Bens S; Oyen F; Wagener R; Giannini C; Perry A; Raisanen JM; Reis GF; Nobusawa S; Arita K; Felsberg J; Reifenberger G; Agaimy A; Buslei R; Capper D; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Paulus W; Kool M; Hasselblatt M
    Am J Surg Pathol; 2018 Apr; 42(4):506-511. PubMed ID: 29324471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An infantile pineal embryonal tumor showing pathological features of a CNS ganglioneuroblastoma and the methylation profiling of an atypical teratoid/rhabdoid tumor and SMARCA4 mutation.
    Fukuoka K; Nakazawa A; Hirato J; Nobusawa S; Itabashi T; Arakawa Y; Mori M; Matsushita Y; Honda S; Tanami Y; Ichimura K; Kurihara J; Koh K
    J Neuropathol Exp Neurol; 2023 Jun; 82(7):664-667. PubMed ID: 37086056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.